 |
|
Phospho-Akt (Thr308) Whole Cell Lysate Kit
|
| The Phospho-Akt (Thr308) Whole Cell Lysate Kit provides assay-specific components for the quantitative determination of phospho-Akt (Ser308) and total Akt in human, mouse, and rat whole cell lysates. |
|
K151DYD-1
|
Phospho-Akt (Thr308) Whole Cell Lysate Kit |
1 plate |
|
K151DYD-2
|
Phospho-Akt (Thr308) Whole Cell Lysate Kit |
5 plates |
|
An ATP-site on-off switch that restricts phosphatase accessibility of Akt.
Lin K, Lin J, Wu WI, Ballard J, Lee BB, Gloor SL, Vigers GP, Morales TH, Friedman LS, Skelton N, Brandhuber BJ.
|
Sci Signal. |
2012 |
|
GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathway.
Wallin, J.J., Edgar, K.A., Guan, J., Berry, M., Prior, W.W., Lee, L., Lesnick, J.D., Lewis, C., Nonomiya, J., Pang, J., Salphati, L., Olivero, A.G., Sutherlin, D.P., O'Brien, C., Spoerke, J.M., Patel, S., Lensun, L., Kassees, R., Ross, L., Lackner, M.R., Sampath, D., Belvin, M., Friedman, L.S.
|
Mol Cancer Ther. |
2011 |
|
Osteopontin Is Required for the Early Onset of High Fat Diet-Induced Insulin Resistance in Mice.
Chapman, J., Miles, P.D., Ofrecio, J.M., Neels, J.G., Yu, J.G., Resnik, J.L., Wilkes, J., Talukdar, S., Thapar, D., Johnson, K., Sears, D.D.
|
PLoS ONE |
2010 |
|
Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
Grund, E.M., Kagan, D., Tran, C.A., Zeitvogel, A., Starzinski-Powitz, A., Nataraja, S., Palmer, S.S.
|
Mol Pharmacol. |
2008 |
|
Development of sulfonamide AKT PH domain inhibitors.
Ahad, A.M., Zuohe, S., Du-Cuny, L., Moses, S.A., Zhou, L.L., Zhang, S., Powis, G., Meuillet, E.J., Mash, E.A.
|
Bioorg Med Chem Lett |
2011 |
|
|
|
|
 |
| Price |
Please call for price |
| Size |
20 plates |
| Catalog No. |
K151DYD-3 |
| Availability |
Usually ships in 1-3 days |
|
Home
Products
K151DYD-3
